C101248

N/A

Report date: 2022/11/17 17:40:53
NME

Base Information

Drug NameC101248
Drug Alias NameC-101248
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium channel subfamily K member 13 inhibitors
TargetsPotassium channel subfamily K member 13
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCerevance Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCerevance Ltd
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A